Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

计划入组 22 人 · 首次发布于 2017 年 9 月 6 日

Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery

计划入组 60 人 · 首次发布于 2018 年 4 月 19 日

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

计划入组 27 人 · 首次发布于 2017 年 9 月 6 日

W4R (Mediolanum Farmaceutici SpA)

Mesoglycan(Mediolanum Farmaceutici SpA)

IL17R inhibitor(Dompe Farmaceutici)

S.M. FARMACEUTICI SRL

Italy

Chiesi Farmaceutici S.p.A.

Italy

ABC FARMACEUTICI SPA

Italy

OncoZenge and Molteni Farmaceutici Partner for BupiZenge Commercialization in Europe

OncoZenge Partners with Meribel Pharma for BupiZenge Phase 3 Manufacturing

OncoZenge Submits Phase III Clinical Trial Application for BupiZenge in Cancer-Related Oral Pain